Zoloft (Sertraline) Onsite Taper

No. You arrive on your current prescribed sertraline dose and the taper is done onsite under continuous cardiac telemetry, bridged with sub-psychoactive full-spectrum iboga total alkaloid at 50–150 mg BID. MindScape does not ask you to attempt a solo washout at home before treatment. A small number of other medications — MAOIs, lithium, tricyclic antidepressants, tramadol and certain QT-prolonging cardiac medications — do still need to be cleared before you arrive, so our medical team reviews your full medication list in advance.

Typically 10–21 days onsite, drug-dependent and dose-dependent. That range is driven by sertraline's intermediate half-life — ≈ 26 hours (active metabolite N-desmethylsertraline ≈ 60–100 hours) — and your baseline dose, usually 25–200 mg/day. Reductions are hyperbolic rather than linear, so the schedule follows how you actually respond instead of running to a fixed calendar.

The sertraline discontinuation profile covers: Brain zaps and electric-shock sensations; Vertigo, dizziness, gait instability; Insomnia and vivid dreaming; Irritability, anxiety surges, derealization; Flu-like fatigue and GI distress. The onsite protocol bridges the taper with sub-psychoactive iboga total alkaloid (50–150 mg BID) to cover the receptor-occupancy gap as your dose comes down, with symptom-driven support and continuous monitoring throughout.

Patients on sertraline for 6+ months have downregulated serotonin transporter (SERT) density. Hyperbolic dose drops below 25 mg are difficult without compounded liquid or bead-counting. SSRI discontinuation syndrome is frequently misdiagnosed as relapse, leading to unnecessary reinstatement.

Yes. Day 0–2 baseline: 12-lead EKG with QTc, CMP, LFTs, electrolytes, thyroid panel. Hyperbolic taper: 50% reduction every 5–7 days using compounded liquid until ≤ 5 mg, then full discontinuation. Iboga TA bridge at 50–150 mg BID covers 5-HT1A/5-HT2A/SERT receptor coverage during the gap. Continuous cardiac telemetry from pre-medication through 72–96 hours post-flood. Magnesium pre-loading and electrolyte normalization before any flood-dose ibogaine HCl.

A flood dose of ibogaine HCl is only administered once sertraline has been reduced to a protocol-defined safe threshold and your cardiac screening is still within limits — eligibility is confirmed at that point rather than promised in advance. Ibogaine is an investigational compound, is not approved by the FDA, and results vary between patients. If your medication picture or your screening makes treatment unsafe, we will tell you honestly.